July 13, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CHICAGO — In a cohort of patients with difficult-to-control type 2 diabetes, approximately one-quarter had hypercortisolism, according to interim results of part 1 of the CAPTAIN-T2D study presented at ENDO 2026. The results are consistent with those of part 1 of the CATALYST trial, in which, as Healio previously reported, 23.8% of patients with difficult-to-control type 2 diabetes had
July 13, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and…

Marker showed 94% accuracy in patients with indeterminate baseline ACTH levels

Dual testing approach can help in decision making, says researcher

CHICAGO — In a small cohort of patients with Cushing’s disease, most had their urinary free cortisol normalized after being…

Stefano Del Prato discusses a shift toward comprehensive, early type 2 diabetes intervention

CHICAGO — Neurological and pancreatic complications are common in patients with congenital hyperinsulinism, according to a…